These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10428208)

  • 41. The role of receptors in the maturation-dependent adenoviral transduction of myofibers.
    Cao B; Pruchnic R; Ikezawa M; Xiao X; Li J; Wickham TJ; Kovesdi I; Rudert WA; Huard J
    Gene Ther; 2001 Apr; 8(8):627-37. PubMed ID: 11320409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus mediated gene transfer to skeletal muscle.
    Cao B; Mytinger JR; Huard J
    Microsc Res Tech; 2002 Jul; 58(1):45-51. PubMed ID: 12112422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
    Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction.
    Park JW; Mok H; Park TG
    J Control Release; 2010 Mar; 142(2):238-44. PubMed ID: 19913577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers.
    Lecollinet S; Gavard F; Havenga MJ; Spiller OB; Lemckert A; Goudsmit J; Eloit M; Richardson J
    J Virol; 2006 Mar; 80(6):2747-59. PubMed ID: 16501084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
    Dudley RW; Lu Y; Gilbert R; Matecki S; Nalbantoglu J; Petrof BJ; Karpati G
    Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.
    Gaden F; Franqueville L; Magnusson MK; Hong SS; Merten MD; Lindholm L; Boulanger P
    J Virol; 2004 Jul; 78(13):7227-47. PubMed ID: 15194799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products.
    Gilbert R; Nalbantoglu J; Howell JM; Davies L; Fletcher S; Amalfitano A; Petrof BJ; Kamen A; Massie B; Karpati G
    Hum Gene Ther; 2001 Sep; 12(14):1741-55. PubMed ID: 11560768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A reduction in the human adenovirus virion size through use of a shortened fibre protein does not enhance muscle transduction following systemic or localised delivery in mice.
    McFall ER; Murray LM; Lunde JA; Jasmin BJ; Kothary R; Parks RJ
    Virology; 2014 Nov; 468-470():444-453. PubMed ID: 25243333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
    Mori S; Wang L; Takeuchi T; Kanda T
    Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscle maturation: implications for gene therapy.
    van Deutekom JC; Hoffman EP; Huard J
    Mol Med Today; 1998 May; 4(5):214-20. PubMed ID: 9612801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA.
    Jani A; Lochmüller H; Acsadi G; Simoneau M; Huard J; Garnier A; Karpati G; Massie B
    J Virol Methods; 1997 Mar; 64(2):111-24. PubMed ID: 9079757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in gene transfer into haematopoietic stem cells by adenoviral vectors.
    Marini FC; Shayakhmetov D; Gharwan H; Lieber A; Andreeff M
    Expert Opin Biol Ther; 2002 Dec; 2(8):847-56. PubMed ID: 12517264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetofection Enhances Adenoviral Vector-based Gene Delivery in Skeletal Muscle Cells.
    Pereyra AS; Mykhaylyk O; Lockhart EF; Taylor JR; Delbono O; Goya RG; Plank C; Hereñu CB
    J Nanomed Nanotechnol; 2016 Apr; 7(2):. PubMed ID: 27274908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.
    Tomita K; Sakurai F; Iizuka S; Hemmi M; Wakabayashi K; Machitani M; Tachibana M; Katayama K; Kamada H; Mizuguchi H
    Sci Rep; 2018 Aug; 8(1):12315. PubMed ID: 30120324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retargeted and detargeted adenovirus for gene delivery to the muscle.
    Nguyen TV; Anguiano-Zarate SS; Matchett WE; Barry ME; Barry MA
    Virology; 2018 Jan; 514():118-123. PubMed ID: 29172089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors.
    Hanayama H; Ohashi K; Utoh R; Shimizu H; Ise K; Sakurai F; Mizuguchi H; Tsuchiya H; Okano T; Gotoh M
    Cell Med; 2015 Dec; 8(1-2):31-8. PubMed ID: 26858906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Capsid-modified adenoviral vectors for improved muscle-directed gene therapy.
    Guse K; Suzuki M; Sule G; Bertin TK; Tyynismaa H; Ahola-Erkkilä S; Palmer D; Suomalainen A; Ng P; Cerullo V; Hemminki A; Lee B
    Hum Gene Ther; 2012 Oct; 23(10):1065-70. PubMed ID: 22888960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineering targeted viral vectors for gene therapy.
    Waehler R; Russell SJ; Curiel DT
    Nat Rev Genet; 2007 Aug; 8(8):573-87. PubMed ID: 17607305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.
    Ghosh D; Barry MA
    J Virol; 2005 Nov; 79(21):13667-72. PubMed ID: 16227286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.